What Researchers Did
Researchers conducted a systematic review of 86 randomised trials involving 10,108 patients to evaluate methods for modifying tumour hypoxia in patients undergoing primary radiation therapy.
What They Found
Modifying tumour hypoxia significantly improved locoregional control with an odds ratio of 0.77 (95% CI, 0.71 to 0.86) and overall survival with an odds ratio of 0.87 (95% CI, 0.80 to 0.95). No significant impact was observed on distant metastases or radiation-related complications.
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for solid tumours may benefit from strategies aimed at reducing tumour hypoxia, potentially leading to better local control and improved survival. These findings suggest that current or future treatments targeting tumour oxygen levels could enhance the effectiveness of their radiotherapy.
Canadian Relevance
This systematic review did not include any specific Canadian data or studies.
Study Limitations
The review's findings may be limited by the considerable heterogeneity observed among individual tumours regarding the presence of hypoxia, potentially affecting the generalizability of the results.